enGene is developing a protein drug delivery system called GEMS (Gut Endocrine-cell Modification System) to deliver peptide therapeutics endogenously from the gut.
EnGene Inc.
Business
Address
We can also tell you EnGene Inc. is a…
If you know more about EnGene Inc., you can add more facts here »
Similar topics in Freebase
-
Regulus Therapeutics
-
Johnson & Johnson
Johnson & Johnson (NYSE: JNJ) is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its... -
ImmunoGen, Inc.
ImmunoGen is developing targeted therapies for Cancer. They have developed tumor activated prodrug (TAP) technologies. -
Biosystems International
Biosystems International is developing monoclonal antibodies for cancer treatment. -
TargAnox
TargAnox is developing therapeutics against oxidative stress. -
ImClone Systems
ImClone Systems Incorporated is a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology. It was founded in 1984 and is headquartered in New York City. On October 6, 2008, it accepted a $6.5 billion acquisition offer from Eli Lilly and Company, and became a... -
Cytochroma
Cytochroma is focused on diseases and disorders related to vitamin D deficiency. -
QLT Inc.
-
Napo Pharmaceuticals
Napo is a developer of products for first world and emerging markets. Napo's first drug, crofelemer, is in clinical trials for gastrointestinal indications. -
Active Biotech AB
You can help improve this topic by adding more facts here
